{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:12Z","timestamp":1793060052982,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jhep.2022.12.010","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T11:39:57Z","timestamp":1671881997000},"page":"704-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Targeting proteostasis of the HEV replicase to combat infection in preclinical models"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-6539","authenticated-orcid":false,"given":"Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-5419","authenticated-orcid":false,"given":"Ling-Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aifu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Neculai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-5443","authenticated-orcid":false,"given":"Pinglong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-8411","authenticated-orcid":false,"given":"Yao-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.12.010_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2018.11.010","article-title":"Evolutionary biology of human hepatitis viruses","volume":"70","author":"Rasche","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib2","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib3","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.13237","article-title":"The global burden of hepatitis E outbreaks: a systematic review","volume":"37","author":"Hakim","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2022.12.010_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"Nimgaonkar","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMc0708687","article-title":"Chronic hepatitis E with cirrhosis in a kidney-transplant recipient","volume":"358","author":"Gerolami","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","author":"Dalton","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","article-title":"Chronic hepatitis after hepatitis E virus infection in a patient with\u00a0non-Hodgkin lymphoma taking rituximab","volume":"150","author":"Ollier","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2022.12.010_bib11","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients","volume":"8","author":"Kamar","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2022.12.010_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1073\/pnas.1614955114","article-title":"Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles","volume":"114","author":"Ding","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.12.010_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00769-18","article-title":"Identification of the intragenomic promoter controlling hepatitis E virus subgenomic RNA transcription","volume":"9","author":"Ding","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.jhep.2022.12.010_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-animal-020518-115117","article-title":"Hepatitis E virus: animal models and Zoonosis","volume":"7","author":"Kenney","year":"2019","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.jhep.2022.12.010_bib15","first-page":"11","article-title":"Stable expression of a hepatitis E virus (HEV) RNA replicon in two mammalian cell lines to assess mechanism of innate immunity and antiviral response","author":"Xu","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhep.2022.12.010_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02193-21","article-title":"Revisiting the Mongolian gerbil model for hepatitis E virus by reverse genetics","author":"Xu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jhep.2022.12.010_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104997","article-title":"Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90","volume":"185","author":"Nimgaonkar","year":"2021","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhep.2022.12.010_bib18","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1128\/JVI.00146-12","article-title":"Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination","volume":"86","author":"Shukla","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.12.010_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008488","article-title":"Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication","volume":"16","author":"Ju","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2022.12.010_bib22","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/jvi.71.4.2583-2590.1997","article-title":"Virus-encoded RNA helicases","volume":"71","author":"Kadare","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2022.12.010_bib23","doi-asserted-by":"crossref","first-page":"39858","DOI":"10.1074\/jbc.M206322200","article-title":"Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function","volume":"277","author":"Basso","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2022.12.010_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hep.32226","article-title":"E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination","volume":"76","author":"Ding","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.12.010_bib25","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.02427-15","article-title":"Antiviral activities of different interferon types and subtypes against hepatitis E virus replication","volume":"60","author":"Todt","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2022.12.010_bib26","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2022.12.010_bib27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.12.010_bib28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A\u00a0mutation in the hepatitis E virus RNA polymerase promotes its replication\u00a0and associates with ribavirin treatment failure in organ transplant\u00a0recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.12.010_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.12.010_bib30","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"Kamar","year":"2012","journal-title":"Hepat E. Lancet"},{"key":"10.1016\/j.jhep.2022.12.010_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrm2918","article-title":"HSP90 at the hub of protein homeostasis: emerging mechanistic insights","volume":"11","author":"Taipale","year":"2010","journal-title":"Nat Rev Mol Cel Biol"},{"key":"10.1016\/j.jhep.2022.12.010_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cel Biol"},{"key":"10.1016\/j.jhep.2022.12.010_bib33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.molcel.2013.12.024","article-title":"Designed Hsp90 heterodimers reveal an asymmetric ATPase-driven mechanism in\u00a0vivo","volume":"53","author":"Mishra","year":"2014","journal-title":"Mol Cel"},{"key":"10.1016\/j.jhep.2022.12.010_bib34","doi-asserted-by":"crossref","first-page":"E358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of HSP90 molecular chaperones: moving into the clinic","volume":"14","author":"Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2022.12.010_bib35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/1535-7163.MCT-11-0667","article-title":"The\u00a0novel oral Hsp90 inhibitor NVP-HSP990 exhibits potent and broad-spectrum antitumor activities in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Menezes","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2022.12.010_bib36","first-page":"453","article-title":"Preclinical activity of the novel orally bioavailable HSP90 inhibitor NVP-HSP990 against multiple myeloma cells","volume":"32","author":"Stuhmer","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jhep.2022.12.010_bib37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/bjc.2014.653","article-title":"A\u00a0first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies","volume":"112","author":"Spreafico","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2022.12.010_bib38","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1038\/ncomms6513","article-title":"HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase beta","volume":"5","author":"Fang","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.12.010_bib39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","article-title":"HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity","volume":"21","author":"Wu","year":"2019","journal-title":"Nat Cel Biol"},{"key":"10.1016\/j.jhep.2022.12.010_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ncb3496","article-title":"Hippo signalling governs cytosolic nucleic acid sensing through YAP\/TAZ-mediated TBK1 blockade","volume":"19","author":"Zhang","year":"2017","journal-title":"Nat Cel Biol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822034626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822034626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:47:11Z","timestamp":1759175231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822034626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0168827822034626"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.12.010","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting proteostasis of the HEV replicase to combat infection in preclinical models","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}